| 02-May-2023 | D | The Board of Directors has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty ) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2023, subject to approval of the Shareholders at the ensuing 29th (Twenty Ninth) Annual General Meeting of the Company.
| 21-Jul-2023 | |
| 02-May-2022 | D | The Board of Directors at its Meeting held on 2nd May, 2022 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e. Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2022, subject to approval of the Shareholders at the ensuing 28th (Twenty Eighth) Annual General Meeting of the Company. | 19-Jul-2022 | |
| 30-Apr-2021 | D | The Board of Directors at its Meeting held on 30th April, 2021 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2021, subject to approval of the Shareholders at the ensuing 27th (Twenty Seventh) Annual General Meeting of the Company. | 22-Jul-2021 | |
| 05-May-2020 | D | The Board of Directors at its Meeting held on 5th May, 2020 have recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2020, subject to approval of the Shareholders at the ensuing 26th (Twenty Sixth) Annual General Meeting of the Company. | 16-Jul-2020 | |
| 30-Apr-2019 | D | The Board of Directors of the Company at its meeting held on 30th April, 2019, inter alia, has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2019, subject to approval of the Shareholders at the ensuing 25th (Twenty Fifth) Annual General Meeting of the Company. | 18-Jul-2019 | |
| 02-May-2018 | D | Astec Lifesciences Ltd has informed BSE that the Meeting of Board of Directors of the Company is scheduled to be held on May 02, 2018, inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2018, after these results are reviewed by the Audit Committee and to consider recommendation of Final Dividend on the Equity Shares of the Company for the Financial Year ended March 31, 2018, if any. | 19-Jul-2018 | |
| 04-May-2017 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 04, 2017 inter alia has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty Only) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2017, subject to approval of the Shareholders at the ensuing 23rd (Twenty Third) Annual General Meeting of the Company. | 17-Jul-2017 | |
| 18-May-2015 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2015, has recommend enhanced dividend of Rs. 1.25/- per share (i.e. 12.50% on the face value of Rs.10/- each) for the period ended March 31, 2015 for the approval of the Shareholders at the ensuing Annual General Meeting, as compared to Rs. 1/- per share (i.e. 10% on the face value of Rs.10/- each) which was declared for the previous year. | 15-Sep-2015 | |
| 30-May-2014 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has transacted the following;
1. Management is pleased to recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each) for the period ended March 31, 2014, for the approval to Seventy Five Paise per share (i.e. 75% on the fact value of Rs. 10/- each) which was declared for the previous year.
2. Accorded its consent to issuance of securities on preferential basis way of issue of Equity Shares/ Preference Shares/ Cumulative Convertible Bonds/ Debentures not exceeding Rupee 25 Crores (shall include premium thereon) at a price which shall be determined in accordance with the Guideline of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009. | 15-Sep-2014 | |
| 24-May-2013 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2013, inter alia, has:
1. Recommended a dividend of Seventy Five paise per share (i.e. 7.5% on face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting. | 02-Sep-2013 | |
| 29-May-2012 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2012, inter alia, has:
Recommended a dividend of fifty paise per share (i.e. 5% on the face value of Rs.10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting. | 13-Sep-2012 | |
| 27-May-2011 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2011, inter alia, has recommended a dividend of fifty paise per share (i.e. 5% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting. | 15-Sep-2011 | |
| 24-May-2010 | D | Astec Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2010, inter alia, recommended a dividend of Re. 1 per share (i.e. 10% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting. | 12-Aug-2010 | |
| 25-Jan-2024 | BC | Kindly find enclosed the Outcome of the Board Meeting held by Astec LifeSciences Limited on January 25, 2024.
Re-appointment of Mr. Anurag Roy as the 'Whole Time Director & Chief Executive Officer | 28-Jul-2024 | |
| 24-Apr-2024 | BC | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve the Standalone and Consolidated Audi | 02-May-2024 | |
| 06-Feb-2024 | BC | Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we are enclosing herewith the Postal Ballot Notice along with the Explanatory Statement seeking approval of the Shareholders for the Spec | 09-Mar-2024 | |
| 12-Jan-2024 | BC | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Notice is hereby given pursuant to R | 25-Jan-2024 | |
| 10-Oct-2023 | BC | ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Notice is hereby given pursuant to R | 27-Oct-2023 | |